Clinical Testing of Beverly Hills

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Purified Exosome Product (PEP) Injected Into the Hypodermis

Phase 1
Not yet recruiting
Conditions
Interventions
First Posted Date
2024-05-24
Last Posted Date
2024-10-21
Lead Sponsor
Clinical Testing of Beverly Hills
Target Recruit Count
9
Registration Number
NCT06429033
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Clinical Testing of Beverly Hills, Encino, California, United States

Xeomin Treatment of Glabellar Lines Using OLD Versus COLD

Early Phase 1
Conditions
Interventions
First Posted Date
2022-03-31
Last Posted Date
2022-03-31
Lead Sponsor
Clinical Testing of Beverly Hills
Target Recruit Count
40
Registration Number
NCT05305768
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Clinical Testing of Beverly Hills, Encino, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Alexander Rivkin MD, Los Angeles, California, United States

Jeuveau Treatment of Glabellar Lines Using OLD Versus COLD

Early Phase 1
Completed
Conditions
Interventions
First Posted Date
2021-11-22
Last Posted Date
2024-02-06
Lead Sponsor
Clinical Testing of Beverly Hills
Target Recruit Count
30
Registration Number
NCT05129319
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Clinical Testing of Beverly Hills, Encino, California, United States

Duration of Botox Using OLD Versus COLD for Treatment of Glabellar Lines

Early Phase 1
Conditions
Interventions
First Posted Date
2021-10-19
Last Posted Date
2021-10-27
Lead Sponsor
Clinical Testing of Beverly Hills
Target Recruit Count
40
Registration Number
NCT05083286
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Steve Yoelin MD, Newport Beach, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Clinical Testing of Beverly Hills, Encino, California, United States

Dysport Dose-Ranging Treatment of Platysmal Bands

Phase 1
Active, not recruiting
Conditions
Interventions
First Posted Date
2021-05-13
Last Posted Date
2022-10-12
Lead Sponsor
Clinical Testing of Beverly Hills
Target Recruit Count
30
Registration Number
NCT04886167
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Clinical Testing of Beverly Hills, Encino, California, United States

ยฉ Copyright 2024. All Rights Reserved by MedPath